Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 28, 2484-2488, December 1, 1968]
© 1968 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Givelber, H.
Right arrow Articles by Schneiderman, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Givelber, H.
Right arrow Articles by Schneiderman, M.

The Influence of Actinomycin D on Survival of X-radiated RF Mice

Harry Givelber, Joseph A. DiPaolo and Marvin Schneiderman

National Cancer Institute, NIH, Bethesda, Maryland 20014

The effect of a single dose of actinomycin D, given at the time of irradiation, on X-radiation-induced leukemia and lymphoma in RF mice was investigated. The mice were treated with 300 R and actinomycin D in combination and separately. As measured by survival analysis, actinomycin D alone did not change either the incidence of lymphomas and/or leukemia, nor the overall survival rates. In combination with X-radiation, actinomycin D was far more toxic in male than in female mice, as manifested by mortality within 30 days after irradiation; it had no effect, however, on subsequent survival nor any consistent effect on the incidence of leukemia. The lack of consistent effects of actinomycin D on long-term survival or on the incidence of leukemia possibly may be related to the time of its administration in relation to X-radiation.

Received 4/ 3/68. Accepted 8/ 7/68.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1968 by the American Association for Cancer Research.